$ABBV · AbbVie Inc.

AbbVie Inc. filed a current report on Form 8-K dated October 30, 2026, announcing its financial results for the third quarter ended September 30, 2026. The company issued a press release with those results, and that press release was furnished as Exhibit 99.1 to the report and incorporated by reference. The filing was made under Item 2.02, which covers results of operations and financial condition.

The report itself does not restate the quarterly financial figures in the excerpt but directs readers to the attached press release for the detailed results. The filing was signed by Scott T. Reents, AbbVie’s Executive Vice President and Chief Financial Officer. No other events or corporate actions are described in this filing.